Alexander Weng
Impact in
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
- Biotechnology top 1%
- Transgenic Plants and Applications
Papers in
- Immunology 48
- Toxin Mechanisms and Immunotoxins 46
-
- Natural product bioactivities and synthesis 25
- Ginseng Biological Effects and Applications 7
- Plant biochemistry and biosynthesis 6
- RNA Interference and Gene Delivery 6
- Plant tissue culture and regeneration 5
- Phytochemical Studies and Bioactivities 5
- Co-authors
- Matthias F. Melzig (38 shared papers)Hendrik Fuchs (38 shared papers)Mayank Thakur (25 shared papers)Roger Gilabert‐Oriol (20 shared papers)Christopher Bachran (13 shared papers)Diana Bachran (10 shared papers)Fuchs (1 shared paper)Christoph D. Garlichs (2 shared papers)
- Journals
- Toxins (6 papers)Planta Medica (5 papers)International Journal of Pharmaceutics (4 papers)Journal of Controlled Release (3 papers)Molecular Oncology (3 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Alexander Weng
64 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 115
- Immunology 892
- Biotechnology 366
- Molecular Biology 1.0k
- Physiology 67
- Biochemistry 68
Countries citing papers authored by Alexander Weng
This map shows the geographic impact of Alexander Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Weng more than expected).
Fields of papers citing papers by Alexander Weng
This network shows the impact of papers produced by Alexander Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Weng. The network helps show where Alexander Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 117 | |
| 2 | 2021 | 113 | |
| 3 | 2005 | 101 | |
| 4 | 2011 | 99 | |
| 5 | 2013 | 97 | |
| 6 | 2015 | 89 | |
| 7 | 2009 | 64 | |
| 8 | 2012 | 64 | |
| 9 | 2014 | 62 | |
| 10 | 2017 | 51 | |
| 11 | 2013 | 48 | |
| 12 | 2016 | 46 | |
| 13 | 2017 | 45 | |
| 14 | 2011 | 41 | |
| 15 | 2012 | 40 | |
| 16 | 2012 | 39 | |
| 17 | 2009 | 39 | |
| 18 | 2010 | 34 | |
| 19 | 2006 | 34 | |
| 20 | 2009 | 33 |
About Alexander Weng
Alexander Weng is a scholar working on Immunology, Molecular Biology, Biotechnology, Plant Science and Analytical Chemistry, having authored 69 papers that have together received 1.8k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (46 papers), Natural product bioactivities and synthesis (25 papers), Transgenic Plants and Applications (14 papers), Ginseng Biological Effects and Applications (7 papers), Plant biochemistry and biosynthesis (6 papers), RNA Interference and Gene Delivery (6 papers), Plant tissue culture and regeneration (5 papers) and Phytochemical Studies and Bioactivities (5 papers). The work is most often cited by research in Immunology (892 citations), Biotechnology (366 citations), Molecular Biology (1.0k citations), Physiology (67 citations) and Biochemistry (68 citations). Alexander Weng has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Matthias F. Melzig, Hendrik Fuchs, Mayank Thakur, Roger Gilabert‐Oriol, Christopher Bachran, Diana Bachran, Fuchs, Christoph D. Garlichs, Christine Reiss and Alexander Steinkasserer. Their work appears in journals such as Toxins, Planta Medica, International Journal of Pharmaceutics, Journal of Controlled Release and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.